Ajooni Biotech Limited — Important, 01-04-2025: General Updates

Ajooni Biotech Limited has received a cautionary email from the National Stock Exchange regarding a prior announcement about an investor/analyst meeting scheduled for May 23, 2024. The NSE pointed out a compliance lapse, noting that the announcement wasn't submitted within the required two working days in advance. The company reassures stakeholders of its commitment to transparency and compliance, emphasizing that it will address the issue seriously and keep investors updated on further developments. This situation may foster caution among investors, highlighting the importance of adherence to regulatory timelines but also suggesting potential for improved governance.